Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission

Published:2018-05 Issue: Volume:15 Page:335-346
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Zhou Hao,Wang Shuyi,Zhu Pingjun,Hu Shunying,Chen Yundai,Ren Jun

Funder

National Natural Science Foundation of China

People Liberation Army General Hospital

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference58 articles.

1. Mff-dependent mitochondrial fission contributes to the pathogenesis of cardiac microvasculature ischemia/reperfusion injury via induction of mROS-mediated cardiolipin oxidation and HK2/VDAC1 disassociation-involved mPTP opening;Zhou;J. Am. Heart Assoc.,2017

2. Endothelial PGC-1alpha mediates vascular dysfunction in diabetes;Sawada;Cell Metab.,2014

3. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus;Hamilton;Diabetes Vasc. Dis. Res.,2007

4. Endothelial cell metabolism in normal and diseased vasculature;Eelen;Circ. Res.,2015

5. The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats;Steven;Redox Biol.,2017

Cited by 410 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11

2. The role of heat shock protein B8 in neuronal protection against oxidative stress and mitochondrial dysfunction: A literature review;International Immunopharmacology;2024-10

3. Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality;Frontiers in Pharmacology;2024-08-30

4. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art;American Journal of Cardiovascular Drugs;2024-08-24

5. SGLT2 inhibitors: how do they affect the cardiac cells;Molecular and Cellular Biochemistry;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3